Skip to content
healthcare.dev

PROMACTA

NDC 0078-0697, eltrombopag olamine, powder, for suspension, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0697
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207027
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0697 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELTROMBOPAG OLAMINE25 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Thrombopoietin Receptor Agonist [EPC]; Thrombopoietin Receptor Agonists [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A3 Inhibitors [MoA]; UGT1A4 Inhibitors [MoA]; UGT1A6 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]; UGT2B15 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]

Package NDCNDC-11Package
0078-0697-61000780697611 CARTON in 1 KIT (0078-0697-61) / 30 PACKET in 1 CARTON (0078-0697-23) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0697-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7714a0ed-34bb-46e6-a0a5-b363908b22c2

Use it

Look up 0078-0697 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0697 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0697. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.